Atossa: Patent De-Risking and Endoxifen Franchise Optionality Support Buy Rating and Upside to Target Price
at www.tipranks.com (Fri, 17-Apr 12:45 PM)
Atossa Therapeutics Resolves Endoxifen Patent Disputes, Clarifies Rights
at www.tipranks.com (Thu, 16-Apr 9:47 AM)
